The survey, developed by researchers at the University of Oxford and digital sleep improvement programme, Sleepio, is the largest of its kind and will provide a snapshot of the nation\u2019s sleep health.
The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre is a \u00a3100M collaboration between Oxford University Hospitals NHS Trust and the University of Oxford to accelerate healthcare innovation. Renewed in 2013, with a 50% increase in funding, the BRC features major neuroscience research themes including cerebrovascular disease and dementia led by Peter Rothwell, and functional neuroscience and imaging led by Peter Brown.
'Sleep disruption is so much more than the inconvenience of being able to sleep at the desired time - it is a global health disruption', said Russell Foster, Professor of Circadian Neuroscience at the University of Oxford, speaking at Wired Health in London on 6 May.
Three students studying for DPhils in the Nuffield Department of Clinical Neurosciences have contributed to Oxford's wins in the women's and men's boat races.
Andrew Farmery of the Nuffield Division of Anaesthetics has co-authored a paper on the first UK study of the use of ketamine intravenous infusions in people with treatment-resistant depression.
The Nuffield Department of Clinical Neurosciences is playing a major role in a new research project looking at how to develop solid-state lighting technology (SSL).
The department was proud to host Professor Dennis J. Selkoe from Harvard Medical School as part of our Litchfield/Thomas Willis lecture and annual postgraduates' meeting.
Tipu Aziz, Professor of Neurosurgery in the Nuffield Department of Clinical Neurosciences, has been awarded the 6th Phillip Gildenberg lectureship in Functional Neurosurgery.
Mr Erlick Pereira, who works with the Nuffield Department of Clinical Neuroscience's Alex Green and Tipu Aziz, has been awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England for 2014 and 2015.
Staff at the Nuffield Division of Anaesthetics have helped the Acute Vascular Imaging Centre to reach a major landmark that could boost care for stroke patients.
The first clinical trial of a gene therapy for an inherited cause of progressive blindness called choroideremia has shown very promising initial results, surpassing the expectations of the researchers involved.
One of the senior researchers in the Nuffield Department of Clinical Neurosciences, Professor Colin Espie, has received a prize for the digital sleep improvement programme that he co-founded with Peter Hames.
The Sleep and Circadian Neuroscience Institute will host a Circadian Neuroscience Summer School for the next five years. We will also be running a Sleep Medicine Summer School in parallel. The five-day Schools will consist of a common first day of introductory lectures for the two schools followed by separate, subject-specific workshops to give all attendees a practical understanding of their subject area.
The Stroke Prevention Research Unit has been awarded the Queen\u2019s Anniversary Prize for Higher Education, the highest form of national recognition that UK higher education institutions can achieve.
Zameel Cader of the Nuffield Department of Clinical Neurosciences will use MRC Technology\u2019s commercialization services to advance new treatments for migraine pain control.
![\"\"](\"https://www.ndcn.ox.ac.uk/news/martin-turner-writes-blog-on-diagnosing-mnd-more-quickly/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n